Denali Therapeutics, Inc. (DNLI)

17.02 +0.21 (+1.25%) USD  |  NASDAQ  |  Dec 18, 12:04
More

Denali Therapeutics Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for DNLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Novavax, Inc. Upgrade
Agenus, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade